Unihealth Hospitals Limited (NSE:UNIHEALTH)
India · Delayed Price · Currency is INR 272.30
-11.15 (-3.93%)
Jan 23, 2026, 3:27 PM IST
Unihealth Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| 789.82 | 555.88 | 487.5 | 439.28 | 368.32 | 262.08 | Upgrade | |
Revenue Growth (YoY) | 56.49% | 14.03% | 10.98% | 19.27% | 40.54% | 17.89% | Upgrade |
Cost of Revenue | 275.46 | 222.12 | 168.22 | 151.85 | 150.43 | 111.39 | Upgrade |
Gross Profit | 514.36 | 333.77 | 319.28 | 287.44 | 217.89 | 150.68 | Upgrade |
Selling, General & Admin | 4.83 | 4.83 | 6.82 | 4.08 | 5.06 | 13.68 | Upgrade |
Other Operating Expenses | 160.58 | 144.03 | 135.7 | 147.02 | 97.77 | 61.42 | Upgrade |
Operating Expenses | 205.54 | 173.6 | 165.15 | 176.26 | 124.96 | 96.93 | Upgrade |
Operating Income | 308.82 | 160.17 | 154.13 | 111.17 | 92.94 | 53.75 | Upgrade |
Interest Expense | -5.83 | -13.13 | -22.24 | -38.93 | -49.71 | -8.9 | Upgrade |
Interest & Investment Income | 17.5 | 17.5 | 13.79 | 5.63 | 3.52 | 0.05 | Upgrade |
Earnings From Equity Investments | 2.3 | -0.21 | -0.81 | 0.02 | -0.76 | -0.3 | Upgrade |
Currency Exchange Gain (Loss) | 9.56 | 9.56 | 1.54 | 12.13 | 5.33 | 8.24 | Upgrade |
Other Non Operating Income (Expenses) | 12.04 | -1.27 | -10.81 | 2.77 | -1.67 | 0.77 | Upgrade |
EBT Excluding Unusual Items | 344.38 | 172.62 | 135.6 | 92.8 | 49.66 | 53.62 | Upgrade |
Pretax Income | 344.38 | 172.62 | 135.6 | 92.8 | 51.28 | 54.44 | Upgrade |
Income Tax Expense | -2.62 | 21.37 | 32.56 | 16.21 | 14.11 | 5.24 | Upgrade |
Earnings From Continuing Operations | 347 | 151.25 | 103.04 | 76.59 | 37.17 | 49.21 | Upgrade |
Minority Interest in Earnings | -95.77 | 0.14 | 0.03 | 0.21 | 1.03 | 0.88 | Upgrade |
Net Income | 251.23 | 151.4 | 103.07 | 76.8 | 38.2 | 50.09 | Upgrade |
Net Income to Common | 251.23 | 151.4 | 103.07 | 76.8 | 38.2 | 50.09 | Upgrade |
Net Income Growth | 122.52% | 46.89% | 34.20% | 101.04% | -23.73% | - | Upgrade |
Shares Outstanding (Basic) | 15 | 15 | 13 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 15 | 15 | 13 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | -0.05% | 14.54% | 21.47% | 0.00% | - | 3.10% | Upgrade |
EPS (Basic) | 16.32 | 9.83 | 7.67 | 6.94 | 3.45 | 4.53 | Upgrade |
EPS (Diluted) | 16.31 | 9.83 | 7.67 | 6.94 | 3.45 | 4.53 | Upgrade |
EPS Growth | 122.61% | 28.23% | 10.48% | 101.12% | -23.76% | - | Upgrade |
Free Cash Flow | -239.59 | -130.99 | 22.95 | -9.9 | 79.68 | 36.97 | Upgrade |
Free Cash Flow Per Share | -15.56 | -8.51 | 1.71 | -0.89 | 7.20 | 3.34 | Upgrade |
Gross Margin | 65.12% | 60.04% | 65.49% | 65.43% | 59.16% | 57.50% | Upgrade |
Operating Margin | 39.10% | 28.81% | 31.62% | 25.31% | 25.23% | 20.51% | Upgrade |
Profit Margin | 31.81% | 27.24% | 21.14% | 17.48% | 10.37% | 19.11% | Upgrade |
Free Cash Flow Margin | -30.34% | -23.56% | 4.71% | -2.25% | 21.63% | 14.11% | Upgrade |
EBITDA | 360.27 | 184.57 | 176.57 | 136.14 | 114.86 | 75.37 | Upgrade |
EBITDA Margin | 45.61% | 33.20% | 36.22% | 30.99% | 31.18% | 28.76% | Upgrade |
D&A For EBITDA | 51.45 | 24.4 | 22.43 | 24.97 | 21.92 | 21.62 | Upgrade |
EBIT | 308.82 | 160.17 | 154.13 | 111.17 | 92.94 | 53.75 | Upgrade |
EBIT Margin | 39.10% | 28.81% | 31.62% | 25.31% | 25.23% | 20.51% | Upgrade |
Effective Tax Rate | - | 12.38% | 24.01% | 17.47% | 27.52% | 9.62% | Upgrade |
Revenue as Reported | 831.37 | 584.13 | 503.53 | 460.3 | 379.27 | 286.35 | Upgrade |
Advertising Expenses | - | - | - | - | 5.06 | 13.68 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.